Jason Mills

Stock Analyst at Canaccord Genuity

(3.12)
# 1,202
Out of 4,711 analysts
116
Total ratings
69.57%
Success rate
34.28%
Average return

Stocks Rated by Jason Mills

Penumbra
Dec 9, 2024
Maintains: Buy
Price Target: $260$323
Current: $242.54
Upside: +33.17%
TransMedics Group
Oct 29, 2024
Maintains: Buy
Price Target: $169$109
Current: $61.70
Upside: +76.66%
STAAR Surgical Company
Apr 26, 2022
Maintains: Buy
Price Target: $81$89
Current: $24.82
Upside: +258.58%
AngioDynamics
Jul 14, 2021
Maintains: Hold
Price Target: $24$28
Current: $8.89
Upside: +214.96%
iRhythm Technologies
Nov 6, 2020
Maintains: Buy
Price Target: $236$273
Current: $90.39
Upside: +202.02%
Merit Medical Systems
Oct 29, 2020
Maintains: Buy
Price Target: $51$55
Current: $98.22
Upside: -44.00%
Neuronetics
Oct 26, 2020
Maintains: Buy
Price Target: $4$8
Current: $1.39
Upside: +475.54%
Nevro
Aug 6, 2020
Maintains: Buy
Price Target: $116$153
Current: $3.79
Upside: +3,936.94%
LeMaitre Vascular
Jul 24, 2020
Maintains: Hold
Price Target: $28$30
Current: $92.12
Upside: -67.43%
Intuitive Surgical
Jul 22, 2020
Maintains: Buy
Price Target: $187$242
Current: $524.43
Upside: -53.92%
Maintains: Hold
Price Target: $66$50
Current: $47.59
Upside: +5.06%
Maintains: Buy
Price Target: $41$45
Current: $30.72
Upside: +46.48%
Maintains: Buy
Price Target: $85$62
Current: $17.00
Upside: +264.71%
Maintains: Buy
Price Target: $43$46
Current: $88.95
Upside: -48.29%
Upgrades: Buy
Price Target: n/a
Current: $82.63
Upside: -
Downgrades: Hold
Price Target: $516,000$120,000
Current: $0.48
Upside: +24,865,212.89%